Exercise for Muscle Atrophy in Chronic Kidney Disease
(EMPHASIS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for muscle atrophy in chronic kidney disease?
Research shows that exercise training can improve muscle strength and physical performance in chronic kidney disease patients, even though it may not significantly increase muscle mass. Exercise also helps improve physical activity levels, which is important because low activity is linked to higher mortality in these patients.12345
Is exercise safe for people with chronic kidney disease?
Research suggests that modest exercise is generally safe for people with chronic kidney disease, and it may help improve muscle function and physical ability. However, the safety of long-term exercise training in this group is still uncertain, and more studies are needed to confirm its safety and benefits.26789
How does exercise differ from other treatments for muscle atrophy in chronic kidney disease?
Exercise is unique because it directly improves muscle strength, endurance, and physical function, which can help prevent muscle loss in chronic kidney disease patients. Unlike medications, exercise is a non-invasive approach that can enhance overall quality of life and reduce mortality rates by addressing physical inactivity and muscle wasting.1391011
What is the purpose of this trial?
The aging Veteran population has more frequent inpatient hospitalization than non-Veterans. In addition, older Veterans have an inability to fully recover muscle mass and function after hospital-acquired weakness. The problem of hospital-acquired weakness is greatly increased in at-risk Veteran populations such as those with chronic kidney disease (CKD). The purpose of this collaborative study involving Denver and Baltimore VAMC sites is to improve health through the detection and rehabilitation management of hospital-acquired weakness in those with CKD. The study goals include identifying and monitoring the optimal muscle assessment sites in clinical settings, examining how muscle health impacts length of hospital stay and physical resilience, and determining how home-based and supervised exercise comparatively addresses post-hospitalization physical resilience using performance tests and Veteran feedback.
Research Team
Michael Harris-Love, DSc MPT BS
Principal Investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
Eligibility Criteria
This trial is for aging Veterans with chronic kidney disease who often experience muscle weakness after hospital stays. Participants should have a history of muscle mass and function loss post-hospitalization. The study excludes those not meeting specific health criteria, which are not detailed here.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline cohort of Veterans with Stage 3 and 4 CKD is established and muscle health is assessed
Treatment
Participants undergo a supervised flywheel strengthening exercise program or receive usual care for 16 weeks
Monitoring
Regular assessments of muscle health every six months and quarterly updates on strength and functional status via smartphone
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor